Ticker brief
BFLY BUTTERFLY NETWORK INC
Consumer, Non-cyclical · Healthcare-Products
last close
$6.76
1 day
-0.7%
14 days
-18.1%
mkt cap
·
signals 14d
24
authors 14d
16
crowd 14d
+0.1σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 113% mid · 71 pctile own 1y | IV/HV 1.30× |
| Skew — 25Δ RR 30d | -0.033 25 pctile own 1y | balanced vs own range |
| OI alarm | quiet | last alarm 2026-06-24 (z=2.2) |
| Next earnings | 2026-10-29 (proj) | in 3d |
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-14 · now +0.10 (−1 bearish … +1 bullish)
Who spoke16
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Ollie_AllCaps | C | -0.10 | 4 | +0.35 |
| @sunxliao | B | -0.09 | 3 | +0.50 |
| @PrismMarketView | C | · | 2 | +0.22 |
| @TalkMarkets | C | · | 2 | +0.45 |
| @PolarizingLit | C | -0.26 | 2 | +0.33 |
| @ShardiB2 | C | -1.82 | 1 | +0.60 |
| @SayNoToTrading | A | -0.55 | 1 | -0.40 |
| @ConsensusGurus | B | -0.54 | 1 | +0.00 |
| @RevShark | B | +1.92 | 1 | +0.40 |
| @FranVezz | C | -1.47 | 1 | +0.40 |
| @pennycheck | A | -1.75 | 1 | +0.35 |
| @AmeetRai | C | -0.17 | 1 | -0.55 |
| @JMRothberg | B | -0.29 | 1 | +0.80 |
| @JeffGabel | B | -2.58 | 1 | +0.65 |
| @Quantumup1 | C | +0.10 | 1 | +0.40 |
| @bullishchart | C | -1.21 | 1 | +0.35 |
Recent signals24of 24 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @PrismMarketView | +0.10 | Highlights three emergency-care medical technology companies. | -11.1% | tweet ↗ |
| 2026-10-12 | @bullishchart | +0.35 | Reports a Bridge Neurotech deal and a bullish 50-day moving-average crossover. | -20.9% | tweet ↗ |
| 2026-10-12 | @sunxliao | +0.25 | Added PDSB to the focused biotech watchlist near a multi-year breakout. — Explicitly adds PDSB while presenting a focused biotech watchlist and breakout thesis. | -20.9% | tweet ↗ |
| 2026-10-12 | @Quantumup1 | +0.40 | Canaccord initiated BFLY at Buy with a $10 target, expecting faster adoption and revenue growth. | -20.9% | tweet ↗ |
| 2026-10-11 | @JeffGabel | +0.65 | Detailed battlefield-deployment thesis for two portable diagnostic companies. | -18.1% | tweet ↗ |
| 2026-10-10 | @sunxliao | +0.50 | Expects strong bullish continuation in biotech after ARKG's monthly retest and cites several prior leaders. | -18.1% | tweet ↗ |
| 2026-10-09 | @JMRothberg | +0.80 | Founder discloses large ownership and strongly positive views of QSI, HYPR and BFLY. | -18.1% | tweet ↗ |
| 2026-10-07 | @AmeetRai | -0.55 | BFLY is again failing at $10 and showing large reversals after up days. | -18.3% | tweet ↗ |
| 2026-10-06 | @PolarizingLit | +0.55 | Frames BFLY as two businesses and argues Embedded may command higher margins and multiples. | -22.3% | tweet ↗ |
| 2026-10-06 | @pennycheck | +0.35 | Reports a newly announced BFLY customer. | -22.3% | tweet ↗ |
| 2026-10-06 | @PolarizingLit | +0.10 | Outlines HYPR machine-sales needs and possible recurring AI and monitoring revenue. | -22.3% | tweet ↗ |
| 2026-10-06 | @FranVezz | +0.40 | Expresses amazement at the named genomics stocks' price action. | -22.3% | tweet ↗ |
| 2026-10-06 | @Ollie_AllCaps | +0.25 | Recaps completed BFLY and SKHY trades, including entries, break-even outcomes and a 3R excursion. | -22.3% | tweet ↗ |
| 2026-10-06 | @RevShark | +0.40 | Sees opportunity in biotech names amid ETF-driven selling and suggests building a stock-picking list. | -22.3% | tweet ↗ |
| 2026-10-06 | @ConsensusGurus | +0.00 | References an attached BFLY chart as one of many similar setups, but gives no direction. | -22.3% | tweet ↗ |
| 2026-10-06 | @SayNoToTrading | -0.40 | Identifies medtech-AI and genomics names dominating the day's losers amid company-specific events. | -22.3% | tweet ↗ |
| 2026-10-06 | @ShardiB2 | +0.60 | Celebrates BFLY breaking above 10. | -22.3% | tweet ↗ |
| 2026-10-05 | @Ollie_AllCaps | +0.65 | Details existing longs, past entries, additions and two new buys within a bullish regime thesis. | -27.9% | tweet ↗ |
| 2026-10-05 | @Ollie_AllCaps | +0.50 | Reports fresh breakouts in BFLY and SIGA. | -27.9% | tweet ↗ |
| 2026-10-04 | @Ollie_AllCaps | +0.00 | Lists three setups being watched for the coming week without entry intent. | -24.5% | tweet ↗ |
| 2026-10-04 | @sunxliao | +0.75 | Says BFLY is ready to run after holding chart support. | -24.5% | tweet ↗ |
| 2026-10-03 | @TalkMarkets | +0.50 | Own the listed stocks before Neuralink goes public. — Explicitly presents a basket of stocks to own ahead of a Neuralink IPO. | -24.5% | tweet ↗ |
| 2026-10-03 | @TalkMarkets | +0.40 | Calls Nasdaq leadership and midterm seasonality bullish through year-end. | -24.5% | tweet ↗ |
| 2026-10-02 | @PrismMarketView | +0.35 | Summarizes product-performance, commercialization, collaboration and research-funding updates across four medtech firms. | -24.5% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.